LakeShore Biopharma News

424B3: Prospectus

May 8 08:33 ET

YS Biopharma | EFFECT: Others

Jan 26 06:10 ET

YS Biopharma | 424B3: Prospectus

Oct 31, 2023 08:46 ET

YS Biopharma | 424B3: Prospectus

Sep 26, 2023 09:13 ET

YS Biopharma | 424B3: Prospectus

Sep 25, 2023 06:12 ET

YS Biopharma | 424B3: Prospectus

Sep 25, 2023 06:07 ET

YS Biopharma | 424B3: Prospectus

Aug 15, 2023 08:00 ET

YS Biopharma | EFFECT: Others

Aug 11, 2023 00:15 ET

YS Biopharma | EFFECT: Others

Jun 6, 2023 00:15 ET

YS Biopharma | 424B3: Prospectus

Jun 5, 2023 16:03 ET

YS Biopharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 14, 2023 17:16 ET

Summit Healthcare Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 14, 2023 17:16 ET

YS Biopharma | 424B3: Prospectus

Feb 21, 2023 07:39 ET

YS Biopharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 21, 2023 07:37 ET

Summit Healthcare Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 21, 2023 07:37 ET

YS Biopharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 8, 2023 09:15 ET

Summit Healthcare Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 8, 2023 09:15 ET

YS Biopharma | 424B3: Prospectus

Feb 8, 2023 08:07 ET

YS Biopharma | EFFECT: Others

Feb 8, 2023 00:15 ET

YS Biopharma | F-4/A: Registration statement for securities issued by foreign private issuers in certain business combination transactions (Amendment)

Feb 3, 2023 09:05 ET